Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan;26(1):139-51.
doi: 10.1007/s11095-008-9721-1. Epub 2008 Sep 9.

Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters

Affiliations

Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters

Patrick J Marsac et al. Pharm Res. 2009 Jan.

Abstract

Purpose: The amorphous form of a drug may provide enhanced solubility, dissolution rate, and bioavailability but will also potentially crystallize over time. Miscible polymeric additives provide a means to increase physical stability. Understanding the miscibility of drug-polymer systems is of interest to optimize the formulation of such systems. The purpose of this work was to develop experimental models which allow for more quantitative estimates of the thermodynamics of mixing amorphous drugs with glassy polymers.

Materials and methods: The thermodynamics of mixing several amorphous drugs with amorphous polymers was estimated by coupling solution theory with experimental data. The entropy of mixing was estimated using Flory-Huggins lattice theory. The enthalpy of mixing and any deviations from the entropy as predicted by Flory-Huggins lattice theory were estimated using two separate experimental techniques; (1) melting point depression of the crystalline drug in the presence of the amorphous polymer was measured using differential scanning calorimetry and (2) determination of the solubility of the drug in 1-ethyl-2-pyrrolidone. The estimated activity coefficient was used to calculate the free energy of mixing of the drugs in the polymers and the corresponding solubility.

Results: Mixtures previously reported as miscible showed various degrees of melting point depression while systems reported as immiscible or partially miscible showed little or no melting point depression. The solubility of several compounds in 1-ethyl-2-pyrrolidone predicts that most drugs have a rather low solubility in poly(vinylpyrrolidone).

Conclusions: Miscibility of various drugs with polymers can be explored by coupling solution theories with experimental data. These approximations provide insight into the physical stability of drug-polymer mixtures and the thermodynamic driving force for crystallization.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Int J Pharm. 2002 Jan 14;231(2):131-44 - PubMed
    1. Drug Dev Ind Pharm. 2002 May;28(5):473-93 - PubMed
    1. Pharm Res. 2006 Oct;23(10):2306-16 - PubMed
    1. J Pharm Sci. 1998 Jun;87(6):694-701 - PubMed
    1. J Pharm Sci. 2000 Oct;89(10):1325-34 - PubMed

Publication types

LinkOut - more resources